INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Directory07Corporate Insiders08Government Money09Political Influence10Institutions11Washington Network12Follow the Power13Disclosure Clock14AI Investigator15Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
01Overview02Follow the Money03Daily Brief04Live05Congress06Directory07Corporate Insiders08Government Money09Political Influence10Institutions11Washington Network12Follow the Power13Disclosure Clock14AI Investigator15Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Corporate insider
DM

Davis Hugh M.

Director, President and COOCIK 0002045027

EDGAR filingsOpen in network
Disclosed transactions6
Buys / sells0 / 0
Max Insider Score21
Connections1with evidence

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
15
DM
Davis Hugh M.Director, President and COO
ACRSAclaris Therapeutics, Inc.
Grant or award
A—
96.1K sh
Feb 2, 2026Feb 6, 2026
traded Feb 2, 2026
+4dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    Aclaris Therapeutics, Inc.Director, President and COO · Dec 4, 2025
15
DM
Davis Hugh M.Director, President and COO
ACRSAclaris Therapeutics, Inc.
Grant or award
A
—
336.3K sh
Feb 2, 2026
Feb 6, 2026
traded Feb 2, 2026
+4d
SEC FORM 4

Evidence

21
DM
Davis Hugh M.Director, President and COO
ACRSAclaris Therapeutics, Inc.
Option exercise
M—
18.7K sh
Feb 3, 2026Feb 5, 2026
traded Feb 3, 2026
+2dSEC FORM 4

Evidence

21
DM
Davis Hugh M.Director, President and COO
ACRSAclaris Therapeutics, Inc.
Option exercise
M—
18.7K sh
Feb 3, 2026Feb 5, 2026
traded Feb 3, 2026
+2dSEC FORM 4

Evidence

9
DM
Davis Hugh M.Director, President and COO
ACRSAclaris Therapeutics, Inc.
Option exercise
M—
26.8K sh
Dec 2, 2025Dec 4, 2025
traded Dec 2, 2025
+2dSEC FORM 4

Evidence

21
DM
Davis Hugh M.Director, President and COO
ACRSAclaris Therapeutics, Inc.
Option exercise
M—
26.8K sh
Dec 2, 2025Dec 4, 2025
traded Dec 2, 2025
+2dSEC FORM 4

Evidence

Data sources
SEC FORM 45m ago
HOUSE PTR4m ago
SEC 13F4m ago
ROBINHOOD CHAIN4m ago